Human epididymis protein 4: Analysis of national health and nutrition examination survey data

The average risk of developing ovarian cancer in the United States is 1 in 78, with the majority of women diagnosed with advanced stage disease (stage III/IV) [1,2]. The benefits and risks associated with screening average-risk women have been studied to include serum blood draws or use of transvaginal ultrasound [3]. Cancer Antigen 125 (CA 125) has low sensitivity in early stages of ovarian cancer, and elevations are also seen in other conditions such as endometriosis or inflammatory conditions of the peritoneum [4,5].
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Full length article Source Type: research